MedPath

Rx Milk Study of Donor Milk Supplementation to Improve Breastfeeding Outcomes

Not Applicable
Completed
Conditions
Breastfeeding Duration
Exclusive Breastfeeding
Donor Milk Supplementation
Registration Number
NCT02221167
Lead Sponsor
Laura Kair
Brief Summary

This study is a randomized controlled trial seeking to determine whether supplementing infants at risk for excessive neonatal weight loss with a small volume of human donor milk prophylactically in the first 1-3 days of life, before maternal mature milk production (before mom's milk "comes in") will decrease the incidence of formula use at 1 week and 1, 2, and 3 months of life and increase the rate of exclusive breastfeeding in this high-risk population.

We hypothesize that supplementation of term infants who have lost greater than or equal to 5% birth weight by 36 hours of age with a small volume of donor breast milk following feeds, until mature milk production, will result in decreased supplemental formula use at 1 week and increased exclusive as well as any breastfeeding at 1 week and 1, 2, and 3 months. This study's specific aims are to compare the effectiveness of encouraging in-hospital exclusive breastfeeding with offering early small-volume donor milk supplementation in a population of infants at risk for excessive neonatal weight loss with goals of 1) decreasing the incidence of formula supplementation at 1 week of life and 2) improving breastfeeding duration.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Gestational age greater than or equal to 37 weeks
  • Weight loss greater than or equal to 5% (rounded to nearest whole percent) of birth weight in the first 36 hours after birth
  • Chronologic age of 24-48 hours old at the time of study enrollment
Exclusion Criteria
  • twins and higher level multiples
  • infant has congenital or chromosomal anomalies that may affect feeding, diagnosed prior to study enrollment
  • mother incarcerated
  • mother's age <18 years
  • mother reports mature milk production prior to study enrollment
  • mother does not speak English
  • infants offered > 1 supplemental feeding of formula or donor milk
  • weight loss greater than 10%

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Any formula use at 1 week of age1 week

Any formula intake within the last 24 hours.

Secondary Outcome Measures
NameTimeMethod
Exclusive breastfeeding2 months
Any breastfeeding at 3 months3 months

Infants receiving some breast milk in addition to some formula in the last 24 hours.

Any breastfeeding1 week

Trial Locations

Locations (1)

University of Iowa Children's Hospital

🇺🇸

Iowa City, Iowa, United States

University of Iowa Children's Hospital
🇺🇸Iowa City, Iowa, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.